Nikita Greenwood
Family · Southlake, TXNPI 1023897097
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 55 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 8.9% — the pattern of someone who eats at a lot of different presentations.
Across 55 payments — averaging $24.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$121
- AstraZeneca$111
- Johnson & Johnson$96
- Dendreon Pharmaceuticals LLC$94
- Incyte Corporation$76
- Caris MPI, Inc.$71
- plus $783 from 22 others
What the payments were for
- Food & beverage$1,352100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 4 | $121 |
| AstraZeneca(2 entities) | 5 | $111 |
| Johnson & Johnson | 5 | $96 |
| Dendreon Pharmaceuticals LLC | 3 | $94 |
| Incyte Corporation | 3 | $76 |
| Caris MPI, Inc. | 3 | $71 |
| Sobi, Inc | 2 | $70 |
| Sanofi | 3 | $64 |
| Merck | 2 | $59 |
| Daiichi Sankyo Inc. | 2 | $51 |
| Servier Pharmaceuticals LLC | 2 | $50 |
| AbbVie | 2 | $47 |
| Bayer | 2 | $45 |
| Gilead | 2 | $41 |
| Pharmaessentia USA Corporation | 1 | $35 |
| Springworks Therapeutics, Inc. | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| AVEO Pharmaceuticals, Inc. | 1 | $32 |
| Novartis | 1 | $31 |
| Coherus Oncology, Inc. | 1 | $27 |
| ADC Therapeutics America, Inc. | 1 | $25 |
| Iovance Biotherapeutics, Inc. | 1 | $24 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $23 |
| Progenics Pharmaceuticals, Inc. | 1 | $23 |
| Taiho Oncology, Inc. | 1 | $22 |
| Tersera Therapeutics LLC | 1 | $20 |
| Puma Biotechnology, Inc. | 1 | $14 |
| Pharmaand GmbH | 1 | $8 |
How this compares
$1,352 in reported general payments places this provider in the 70th percentile of 15,456 family providers in Texas.
Other family in Southlake
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
- Angela AchaPflugerville$174K
- Susan BowlinIrving$164K
- Stephanie RodriguezCorpus Christi$159K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.